Admera Health Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
55

- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$1.27M
- Investors
-
3
Admera Health General Information
Description
Operator of a molecular diagnostics center intended to improve the health and well-being of the global community through direct delivery of personalized, medically actionable results. The company offers clinical diagnostics focused on research and development of personalized medicine and non-invasive cancer testing by utilizing advanced genomic technologies and bioinformatics analysis, enabling patients, physicians and clinical researchers to redefine disease screening, diagnosis, treatment, monitoring and management through its personalized drugs.
Contact Information
Website
www.admerahealth.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
- 126 Corporate Boulevard
- South Plainfield, NJ 07080
- United States
+1 (908) 000-0000
Admera Health Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Debt - PPP | 05-Apr-2020 | $1.27M | Completed | Generating Revenue | ||
1. Early Stage VC (Series A) | 07-Apr-2015 | Completed | Generating Revenue |
Admera Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a molecular diagnostics center intended to improve the health and well-being of the global community through
Biotechnology
South Plainfield, NJ
55
As of 2023
000000000 -
Admera Health Competitors (29)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Ambry Genetics | Corporate Backed or Acquired | Aliso Viejo, CA | 000 | 000000&0 | ||
00000000 | Formerly VC-backed | Boulder, CO | 000 | 00000 | 000000000 | 00000 |
00000000 | Formerly PE-Backed | Miami, FL | 000 | 000000&0 | ||
000000000 | Private Equity-Backed | Foster City, CA | 000 | 00000 | 0000000 0000 | 00000 |
0000 00000000000 | Formerly PE-Backed | Hayward, CA | 0 | 000000000 - |
Admera Health Patents
Admera Health Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200277651-A1 | Nucleic acid preparation and analysis | Inactive | 17-Feb-2016 | 000000000 | |
US-20170327868-A1 | Blocker based enrichment system and uses thereof | Inactive | 21-Oct-2015 | 0000000000 | 0 |
US-20160070881-A1 | System, method and graphical user interface for creating modular, patient transportable genomic analytic data | Inactive | 05-Sep-2014 | ||
EP-3189456-A1 | System, method and graphical user interface for creating modular, patient transportable genomic analytic data | Inactive | 05-Sep-2014 | G16H10/60 |
Admera Health Executive Team (7)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Allen Osofsky | Controller | ||
Jeffrey Mitchell | Vice President |
Admera Health Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Chenhui Wen Ph.D | Prime Value Capital Management | Board Member | 000 0000 |
Admera Health Signals
Admera Health Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Prime Value Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | |
SummitView Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
YuanBio Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Admera Health Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 000 | 01-Jan-2019 | 0000000000 | Biotechnology |